|
|
||||||||
The Journal of Immunology, Vol 158, Issue 1 235-246, Copyright © 1997 by American Association of Immunologists
ARTICLES |
TA Johnson, LZ Rassenti and TJ Kipps
Division of Hematology/Oncology, Department of Medicine, University of California-San Diego, La Jolla 92093, USA.
Prior studies revealed that the leukemic B cells of patients with chronic lymphocytic leukemia (CLL) express a restricted Ig heavy chain variable region gene (VH gene) repertoire. However, this restriction needs to be re-evaluated in light of findings that the repertoire of Ig VH genes used by primary B cells of normal adults is actually more restricted than originally assumed. Because of this, we critically examined the Ig VH1 and VH7 genes expressed by leukemia cells of a random panel of patients with B cell CLL (n = 117). Forty-one (35%) had leukemia cells with functional VH1 gene rearrangements. Of these, the large majority expressed Ig VH1-69 (n = 26; 63%). The remaining leukemia cell samples expressed VH1-2 (n = 4; 10%), VH1-3 (n = 2; 5%), VH1-8 (n = 2; 5%), VH1-18 (n = 1; 2%), VH1-45 (n = 1; 2%), and VH1-46 (n = 5; 12%). Only 1 of the 117 examined (<1%) used Ig VH genes of the VH7 subgroup. We found that certain alleles of the IgVH1-69 locus are favored in CLL. Also, leukemia B cells that express VH1-69 have a distinctive use distribution of D and JH gene segments compared with that of VH1-expressing CLL B cells that do not use VH1-69 or non- neoplastic B cells that express VH1-69. Finally, the average length of the heavy chain third complementarity-determining regions (CDR3) of VH1- 69-expressing leukemia cells is significantly longer than that of normal adult B cells that also express Ig encoded by VH1-69 genes. Collectively, this study indicates that the Ig expressed in CLL have distinctive molecular features that are not representative of the Ig expressed by primary B cells of normal adults.
This article has been cited by other articles:
![]() |
F. Caligaris-Cappio and P. Ghia Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease? J. Clin. Oncol., September 20, 2008; 26(27): 4497 - 4503. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Widhopf II, C. J. Goldberg, T. L. Toy, L. Z. Rassenti, W. G. Wierda, J. C. Byrd, M. J. Keating, J. G. Gribben, K. R. Rai, and T. J. Kipps Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3 Blood, March 15, 2008; 111(6): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kipps Chronic Lymphocytic Leukemia: Prognostic Markers and Revised Criteria for Treatment and Response Assessment ASCO Educational Book, January 1, 2008; 2008(1): 286 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kriangkum, B. J. Taylor, S. P. Treon, M. J. Mant, T. Reiman, A. R. Belch, and L. M. Pilarski Molecular Characterization of Waldenstrom's Macroglobulinemia Reveals Frequent Occurrence of Two B-Cell Clones Having Distinct IgH VDJ Sequences Clin. Cancer Res., April 1, 2007; 13(7): 2005 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bomben, M. Dal Bo, D. Capello, D. Benedetti, D. Marconi, A. Zucchetto, F. Forconi, R. Maffei, E. M. Ghia, L. Laurenti, et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study Blood, April 1, 2007; 109(7): 2989 - 2998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Volkheimer, J. B. Weinberg, B. E. Beasley, J. F. Whitesides, J. P. Gockerman, J. O. Moore, G. Kelsoe, B. K. Goodman, and M. C. Levesque Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification Blood, February 15, 2007; 109(4): 1559 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stamatopoulos, C. Belessi, C. Moreno, M. Boudjograh, G. Guida, T. Smilevska, L. Belhoul, S. Stella, N. Stavroyianni, M. Crespo, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations Blood, January 1, 2007; 109(1): 259 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-j. Yan, E. Albesiano, N. Zanesi, S. Yancopoulos, A. Sawyer, E. Romano, A. Petlickovski, D. G. Efremov, C. M. Croce, and N. Chiorazzi B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia PNAS, August 1, 2006; 103(31): 11713 - 11718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thorselius, A. Krober, F. Murray, U. Thunberg, G. Tobin, A. Buhler, D. Kienle, E. Albesiano, R. Maffei, L.-P. Dao-Ung, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status Blood, April 1, 2006; 107(7): 2889 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Falt, M. Merup, G. Tobin, U. Thunberg, G. Gahrton, R. Rosenquist, and A. Wennborg Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia Blood, July 15, 2005; 106(2): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Grabowski, M. Hultdin, K. Karlsson, G. Tobin, A. Aleskog, U. Thunberg, A. Laurell, C. Sundstrom, R. Rosenquist, and G. Roos Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status Blood, June 15, 2005; 105(12): 4807 - 4812. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chiorazzi, K. R. Rai, and M. Ferrarini Chronic Lymphocytic Leukemia N. Engl. J. Med., February 24, 2005; 352(8): 804 - 815. [Full Text] [PDF] |
||||
![]() |
G. Dighiero CLL Biology and Prognosis Hematology, January 1, 2005; 2005(1): 278 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tobin, U. Thunberg, K. Karlsson, F. Murray, A. Laurell, K. Willander, G. Enblad, M. Merup, J. Vilpo, G. Juliusson, et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia Blood, November 1, 2004; 104(9): 2879 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Widhopf II, L. Z. Rassenti, T. L. Toy, J. G. Gribben, W. G. Wierda, and T. J. Kipps Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins Blood, October 15, 2004; 104(8): 2499 - 2504. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Messmer, E. Albesiano, D. G. Efremov, F. Ghiotto, S. L. Allen, J. Kolitz, R. Foa, R. N. Damle, F. Fais, D. Messmer, et al. Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia J. Exp. Med., August 16, 2004; 200(4): 519 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Stevenson and F. Caligaris-Cappio Chronic lymphocytic leukemia: revelations from the B-cell receptor Blood, June 15, 2004; 103(12): 4389 - 4395. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Messmer, E. Albesiano, D. Messmer, and N. Chiorazzi The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process Blood, May 1, 2004; 103(9): 3490 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Widhopf II, D. C. Brinson, T. J. Kipps, and H. Tighe Transgenic Expression of a Human Polyreactive Ig Expressed in Chronic Lymphocytic Leukemia Generates Memory-Type B Cells That Respond to Nonspecific Immune Activation J. Immunol., February 15, 2004; 172(4): 2092 - 2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tobin, U. Thunberg, A. Johnson, I. Eriksson, O. Soderberg, K. Karlsson, M. Merup, G. Juliusson, J. Vilpo, G. Enblad, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted V{lambda}2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope Blood, June 15, 2003; 101(12): 4952 - 4957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Walsh, M. Thorselius, A. Johnson, O. Soderberg, M. Jerkeman, E. Bjorck, I. Eriksson, U. Thunberg, O. Landgren, M. Ehinger, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma Blood, May 15, 2003; 101(10): 4047 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Potter, J. Orchard, E. Critchley, C. I. Mockridge, A. Jose, and F. K. Stevenson Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire Blood, April 15, 2003; 101(8): 3082 - 3084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Rezvany, M. Jeddi-Tehrani, H. Wigzell, A. Osterborg, and H. Mellstedt Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia Blood, February 1, 2003; 101(3): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Keating, N. Chiorazzi, B. Messmer, R. N. Damle, S. L. Allen, K. R. Rai, M. Ferrarini, and T. J. Kipps Biology and Treatment of Chronic Lymphocytic Leukemia Hematology, January 1, 2003; 2003(1): 153 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Edwards, W. Brouwer, C. H. Y. Choi, J. Ruhno, R. L. Ward, and A. M. Collins Analysis of IgE Antibodies from a Patient with Atopic Dermatitis: Biased V Gene Usage and Evidence for Polyreactive IgE Heavy Chain Complementarity-Determining Region 3 J. Immunol., June 15, 2002; 168(12): 6305 - 6313. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Damle, F. Ghiotto, A. Valetto, E. Albesiano, F. Fais, X.-J. Yan, C. P. Sison, S. L. Allen, J. Kolitz, P. Schulman, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes Blood, May 13, 2002; 99(11): 4087 - 4093. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tobin, U. Thunberg, A. Johnson, I. Thorn, O. Soderberg, M. Hultdin, J. Botling, G. Enblad, J. Sallstrom, C. Sundstrom, et al. Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia Blood, March 15, 2002; 99(6): 2262 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rosenwald, A. A. Alizadeh, G. Widhopf, R. Simon, R. E. Davis, X. Yu, L. Yang, O. K. Pickeral, L. Z. Rassenti, J. Powell, et al. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia J. Exp. Med., December 3, 2001; 194(11): 1639 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marasca, P. Vaccari, M. Luppi, P. Zucchini, I. Castelli, P. Barozzi, A. Cuoghi, and G. Torelli Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma Am. J. Pathol., July 1, 2001; 159(1): 253 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Chan, K. G. Hadlock, S. K. H. Foung, and S. Levy VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen Blood, February 15, 2001; 97(4): 1023 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Widhopf II and T. J. Kipps Normal B Cells Express 51p1-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells J. Immunol., January 1, 2001; 166(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Wierda, M. J. Cantwell, S. J. Woods, L. Z. Rassenti, C. E. Prussak, and T. J. Kipps CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia Blood, November 1, 2000; 96(9): 2917 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Bahler, N. S. Aguilera, C. C. Chen, S. L. Abbondanzo, and S. H. Swerdlow Histological and Immunoglobulin VH Gene Analysis of Interfollicular Small Lymphocytic Lymphoma Provides Evidence for Two Types Am. J. Pathol., October 1, 2000; 157(4): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Miklos, S. H. Swerdlow, and D. W. Bahler Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin VH genes show frequent use of V1-69 with distinctive CDR3 features Blood, June 15, 2000; 95(12): 3878 - 3884. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakai, G. E. Marti, N. Caporaso, S. Pittaluga, J. W. Touchman, F. Fend, and M. Raffeld Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL Blood, February 15, 2000; 95(4): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Decker, F. Schneller, T. Sparwasser, T. Tretter, G. B. Lipford, H. Wagner, and C. Peschel Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells Blood, February 1, 2000; 95(3): 999 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kearns-Jonker, J. Swensson, C. Ghiuzeli, W. Chu, Y. Osame, V. Starnes, and D. V. Cramer The Human Antibody Response to Porcine Xenoantigens Is Encoded by IGHV3-11 and IGHV3-74 IgVH Germline Progenitors J. Immunol., October 15, 1999; 163(8): 4399 - 4412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Damle, T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S. L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, et al. Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia Blood, September 15, 1999; 94(6): 1840 - 1847. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Hamblin, Z. Davis, A. Gardiner, D. G. Oscier, and F. K. Stevenson Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia Blood, September 15, 1999; 94(6): 1848 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ivanovski, F. Silvestri, G. Pozzato, S. Anand, C. Mazzaro, O. R. Burrone, and D. G. Efremov Somatic Hypermutation, Clonal Diversity, and Preferential Expression of the VH 51p1/VL kv325 Immunoglobulin Gene Combination in Hepatitis C Virus-Associated Immunocytomas Blood, April 1, 1998; 91(7): 2433 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Bahler and S. H. Swerdlow Clonal Salivary Gland Infiltrates Associated With Myoepithelial Sialadenitis (Sjogren's Syndrome) Begin as Nonmalignant Antigen-Selected Expansions Blood, March 15, 1998; 91(6): 1864 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Schettino, A. Cerutti, N. Chiorazzi, and P. Casali Lack of Intraclonal Diversification in Ig Heavy and Light Chain V Region Genes Expressed by CD5+IgM+ Chronic Lymphocytic Leukemia B Cells: A Multiple Time Point Analysis J. Immunol., January 15, 1998; 160(2): 820 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Sahota, R. Garand, R. Bataille, A. J. Smith, and F. K. Stevenson VH Gene Analysis of Clonally Related IgM and IgG From Human Lymphoplasmacytoid B-Cell Tumors With Chronic Lymphocytic Leukemia Features and High Serum Monoclonal IgG Blood, January 1, 1998; 91(1): 238 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kosmas, K. Stamatopoulos, D. Loukopoulos;, F. K. Stevenson, and S.S. Sahota Antigen Selection of Multiple Myeloma Clonogenic B Cells as Evidenced by VH and VL Gene Mutations Blood, August 1, 1997; 90(3): 1334 - 1334. [Full Text] [PDF] |
||||
![]() |
L. Z. Rassenti and T. J. Kipps Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia J. Exp. Med., April 21, 1997; 185(8): 1435 - 1446. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |